Dow futures rise slightly after average hits new yearly high: Live updates –
45 minutes ago Pfizer shares are falling after the company stops developing experimental weight-loss drugs Pfizer shares fell about 4% in premarket trading after the drugmaker decided to stop developing a twice-daily version of its weight-loss drug due to adverse side effects. “At this time, the twice-daily danuglipron formulation will not advance to Phase 3 … [Read more…]